1. Home
  2. NMRA vs SNFCA Comparison

NMRA vs SNFCA Comparison

Compare NMRA & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • SNFCA
  • Stock Information
  • Founded
  • NMRA 2019
  • SNFCA 1965
  • Country
  • NMRA United States
  • SNFCA United States
  • Employees
  • NMRA N/A
  • SNFCA N/A
  • Industry
  • NMRA
  • SNFCA Finance: Consumer Services
  • Sector
  • NMRA
  • SNFCA Finance
  • Exchange
  • NMRA Nasdaq
  • SNFCA Nasdaq
  • Market Cap
  • NMRA 291.5M
  • SNFCA 234.1M
  • IPO Year
  • NMRA 2023
  • SNFCA N/A
  • Fundamental
  • Price
  • NMRA $3.01
  • SNFCA $8.10
  • Analyst Decision
  • NMRA Buy
  • SNFCA
  • Analyst Count
  • NMRA 8
  • SNFCA 0
  • Target Price
  • NMRA $7.43
  • SNFCA N/A
  • AVG Volume (30 Days)
  • NMRA 3.0M
  • SNFCA 23.1K
  • Earning Date
  • NMRA 11-06-2025
  • SNFCA 11-14-2025
  • Dividend Yield
  • NMRA N/A
  • SNFCA N/A
  • EPS Growth
  • NMRA N/A
  • SNFCA 2.26
  • EPS
  • NMRA N/A
  • SNFCA 0.89
  • Revenue
  • NMRA N/A
  • SNFCA $339,824,006.00
  • Revenue This Year
  • NMRA N/A
  • SNFCA N/A
  • Revenue Next Year
  • NMRA N/A
  • SNFCA N/A
  • P/E Ratio
  • NMRA N/A
  • SNFCA $8.99
  • Revenue Growth
  • NMRA N/A
  • SNFCA 5.49
  • 52 Week Low
  • NMRA $0.61
  • SNFCA $7.32
  • 52 Week High
  • NMRA $14.09
  • SNFCA $12.94
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 75.77
  • SNFCA 43.05
  • Support Level
  • NMRA $2.40
  • SNFCA $7.97
  • Resistance Level
  • NMRA $3.25
  • SNFCA $8.53
  • Average True Range (ATR)
  • NMRA 0.27
  • SNFCA 0.29
  • MACD
  • NMRA 0.11
  • SNFCA 0.00
  • Stochastic Oscillator
  • NMRA 84.76
  • SNFCA 31.75

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

Share on Social Networks: